KR102585227B1 - Composition for stabilizing polyphenolic effective ingredient - Google Patents
Composition for stabilizing polyphenolic effective ingredient Download PDFInfo
- Publication number
- KR102585227B1 KR102585227B1 KR1020230026734A KR20230026734A KR102585227B1 KR 102585227 B1 KR102585227 B1 KR 102585227B1 KR 1020230026734 A KR1020230026734 A KR 1020230026734A KR 20230026734 A KR20230026734 A KR 20230026734A KR 102585227 B1 KR102585227 B1 KR 102585227B1
- Authority
- KR
- South Korea
- Prior art keywords
- composition
- polyphenol
- based active
- producing
- silica
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0216—Solid or semisolid forms
- A61K8/022—Powders; Compacted Powders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
- A61K8/0279—Porous; Hollow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/87—Polyurethanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
Abstract
본 발명은 난용성인 폴리페놀계 유효 성분 안정화용 조성물에 관한 것으로, 파우더와 보습 효능성분을 이용하여 폴리페놀계 난용성 유효 성분의 제형 내에서의 석출 문제를 해결하고, 동시에 피부안전성도 우수한 조성물에 관한 것이다.The present invention relates to a composition for stabilizing poorly soluble polyphenol-based active ingredients, which solves the problem of precipitation of poorly soluble polyphenol-based active ingredients in formulations by using powder and moisturizing ingredients, and at the same time provides a composition with excellent skin safety. It's about.
Description
본 발명은 폴리페놀계 유효 성분 안정화용 조성물에 관한 것이다.The present invention relates to a composition for stabilizing polyphenol-based active ingredients.
피부에 미백, 주름개선 또는 기타 피부개선 효능을 부여하는 성분(이하, 효능 성분)들 중에는 예를 들면, 폴리페놀계처럼 물이나 오일 어느 것에도 거의 녹지 않는 난용성 물질들이 다수 존재한다. 따라서 상기 효능 성분을 화장품에 고함량 사용하기 위해 이를 안정화시키는 다양한 방법들이 시도되어 왔다.Among the ingredients (hereinafter referred to as efficacy ingredients) that provide skin whitening, wrinkle improvement, or other skin improvement effects, there are many poorly soluble substances that are almost insoluble in either water or oil, such as polyphenols, for example. Therefore, various methods have been attempted to stabilize the effective ingredients in order to use them in high amounts in cosmetics.
물이 포함되지 않는 무수 제형을 이용한 크림이나 스팟 전용화장품의 경우, 물에 산화되기 쉽거나 석출이 되는 성분들의 안정화 및 열감을 부여함으로써 차별화된 장점을 부여하고자 하였다(특허문헌 1). 그러나 경시에 따른 불안정성 및 무겁고 답답한 사용감 등의 문제를 여전히 가지고 있었다. In the case of creams or spot cosmetics using an anhydrous formulation that does not contain water, an attempt was made to provide differentiated advantages by stabilizing ingredients that are easily oxidized or precipitated in water and providing heat (Patent Document 1). However, it still had problems such as instability due to aging and a heavy and frustrating feeling in use.
이와 같은 제형화 기술과 더불어, 양친성 블록 공중합체를 이용한 고분자 마이셀 또는 나노파티클 형성 기술들을 이용한 난용성 약물의 안정화 및 효능 최적화(특허문헌 2,3, 비특허문헌 1), Nanostructured lipid carrier를 이용한 폴리페놀계(제니스테인) 유효 성분의 효능 최적화(비특허문헌 2) 등의 다수의 연구들이 진행되었다.In addition to these formulation technologies, stabilization and efficacy optimization of poorly soluble drugs using polymer micelle or nanoparticle formation technologies using amphiphilic block copolymers (Patent Documents 2 and 3, Non-Patent Document 1), and nanostructured lipid carriers A number of studies have been conducted, such as optimizing the efficacy of polyphenol-based (genistein) active ingredients (Non-Patent Document 2).
그러나 이와 같은 방법으로 화장품 제형을 제조 시, 경시에 따른 석출 문제를 여전히 가지고 있어 난용성 성분을 고함량으로 사용하기에는 한계가 있었다. However, when manufacturing cosmetic formulations using this method, there is still a problem of precipitation over time, so there is a limit to using poorly soluble ingredients in high amounts.
본 발명은 난용성인 폴리페놀계 유효 성분을 화장료 제형 내에 안정화시킬 수 있는 조성물을 제공하고자 한다.The present invention seeks to provide a composition that can stabilize poorly soluble polyphenol-based active ingredients in cosmetic formulations.
또한 본 발명은 사용감이 우수하고, 피부 자극이 없는 화장물 조성물을 제공하고자 한다.In addition, the present invention seeks to provide a cosmetic composition that has an excellent feeling of use and does not cause skin irritation.
본 발명에서는 다공성 고분자 입자, 및 사이클로덱스트린 또는 그 유도체로 이루어진 그룹에서 선택된 하나 이상을 포함하는 파우더; 및 In the present invention, a powder containing at least one selected from the group consisting of porous polymer particles and cyclodextrin or a derivative thereof; and
베타인, 알라닐글루타민, 폴리쿼터늄-51, 니코틴아미드, 우레아 또는 그 유도체, 및 소듐피씨에이로 이루어진 그룹에서 선택된 하나 이상을 포함하는 보습성분을 포함하는 폴리페놀계 유효 성분 안정화용 조성물을 제공한다. Provides a composition for stabilizing polyphenol-based active ingredients containing a moisturizing ingredient including one or more selected from the group consisting of betaine, alanylglutamine, polyquaternium-51, nicotinamide, urea or its derivatives, and sodium PCA. do.
또한, 본 발명에서는 전술한 폴리페놀계 유효 성분 안정화용 조성물을 포함하는 화장료 조성물을 제공한다.Additionally, the present invention provides a cosmetic composition containing the composition for stabilizing the polyphenol-based active ingredient described above.
본 발명에 따른 폴리페놀계 유효 성분 안정화용 조성물은 피부에 자극이 없으며, 폴리페놀계 유효 성분의 용해도를 향상시킴으로써 화장료 제형 내에서 안정화시킬 수 있다.The composition for stabilizing polyphenol-based active ingredients according to the present invention does not irritate the skin, and can be stabilized in cosmetic formulations by improving the solubility of polyphenol-based active ingredients.
본 발명은 다공성 고분자 입자, 및 사이클로덱스트린 또는 그 유도체로 이루어진 그룹에서 선택된 하나 이상을 포함하는 파우더; 및 The present invention relates to a powder containing at least one selected from the group consisting of porous polymer particles and cyclodextrin or a derivative thereof; and
베타인, 알라닐글루타민, 폴리쿼터늄-51, 니코틴아미드, 우레아 또는 그 유도체, 및 소듐피씨에이로 이루어진 그룹에서 선택된 하나 이상을 포함하는 보습성분을 포함하는 폴리페놀계 유효 성분 안정화용 조성물에 관한 것이다. About a composition for stabilizing polyphenol-based active ingredients containing a moisturizing ingredient containing at least one selected from the group consisting of betaine, alanylglutamine, polyquaternium-51, nicotinamide, urea or its derivatives, and sodium PCA. will be.
이하, 본 발명에 따른 폴리페놀계 유효 성분 안정화용 조성물을 보다 상세하게 설명한다. Hereinafter, the composition for stabilizing polyphenol-based active ingredients according to the present invention will be described in more detail.
본 발명에서 폴리페놀계 유효 성분은 제니스테인, 다이드제인, 프란게니딘, 폴리다틴, 디오스메틴, 메이스리그난, 아시아티코사이드, 진세노사이드알이, 속수자 종자추출물, 글리시테인, 퀘르세틴, 카테킨, 페오놀,레스베라트롤, 헤스페레틴, 및 레스페리딘으로 이루어진 그룹에서 선택된 하나 이상을 포함할 수 있다. 또한 상기 폴리페놀계 유효 성분은 상기 폴리페놀의 유도체 또는 상기 폴리페놀로부터 유래된 효능 성분을 포함할 수 있다. In the present invention, the polyphenol-based active ingredients include genistein, daidzein, frangenidin, polydatin, diosmetin, macelignan, asiaticoside, ginsenoside egg, prickly pear seed extract, glycitein, quercetin, catechin, It may include one or more selected from the group consisting of pheonol, resveratrol, hesperetin, and resperidin. Additionally, the polyphenol-based active ingredient may include a derivative of the polyphenol or an effective ingredient derived from the polyphenol.
상기 폴리페놀계 유효 성분은 물이나 오일 어느 것에도 거의 녹지 않는 난용성 성분으로, 폴리페놀계 유효 성분을 화장료 조성물 등에 사용하기 위해서는 상기 폴리페놀계 유효 성분을 안정화 시켜야 한다. The polyphenol-based active ingredient is a poorly soluble ingredient that is almost insoluble in either water or oil. In order to use the polyphenol-based active ingredient in cosmetic compositions, etc., the polyphenol-based active ingredient must be stabilized.
이를 위해, 본 발명에서는 파우더 및 보습성분을 함께 사용하여, 폴리페놀계 유효 성분의 용해도를 현저하게 향상시켜 조성물 내에서 상기 성분을 안정화시킬 수 있다. 이러한 안정화 효과는 파우더 및 보습성분을 각각 단독으로 사용할 경우에 비해 시너지적으로 증진된 것으로, 보습 효능성분에 의한 안정화는 물론, 파우더 내부에 포집 되는 것에 기인하는 것으로 예측된다.To this end, in the present invention, powder and moisturizing ingredients can be used together to significantly improve the solubility of polyphenol-based active ingredients and stabilize the ingredients within the composition. This stabilization effect is synergistically enhanced compared to when the powder and moisturizing ingredients are used alone, and is expected to be due to not only stabilization by the moisturizing ingredients but also being trapped inside the powder.
본 발명에서 파우더는 통상적으로 조성물에 소프트한 감촉을 부여하고, 흡수성을 높여주며 번들거림이나 끈적임을 막아주는 기능을 수행한다. 본 발명에서 상기 파우더는 폴리페놀계 난용성 유효 성분의 석출을 방지하기 위해 사용될 수 있다. In the present invention, powder typically provides a soft texture to the composition, increases absorbency, and prevents shine or stickiness. In the present invention, the powder can be used to prevent precipitation of polyphenol-based poorly soluble active ingredients.
이러한 파우더의 종류는 특별히 제한되지 않으며, 다공성 고분자 입자, 및 사이클로덱스트린 또는 그 유도체로 이루어진 그룹에서 선택된 하나 이상을 사용할 수 있다. The type of this powder is not particularly limited, and one or more selected from the group consisting of porous polymer particles and cyclodextrin or its derivatives can be used.
일 구체예에서, 다공성 고분자 입자는 폴리우레탄 유도체, 실리카(Silica), 다공성 셀룰로오스(Porous Cellulose), 폴리메틸메타아크릴레이트 (Polymethylmethacrylate), 알릴메타아크릴레이트 크로스폴리머(Allyl methacrylates crosspolymer) 및 폴리아미드(Polyamide)로 이루어진 그룹에서 선택된 하나 이상을 포함할 수 있다. In one embodiment, the porous polymer particles include polyurethane derivatives, silica, porous cellulose, polymethylmethacrylate, allyl methacrylates crosspolymer, and polyamide. ) may include one or more selected from the group consisting of
상기 폴리우레탄 유도체는 예를 들어, 에이치디아이/트리메틸롤헥실락톤 크로스폴리머 & 실리카(HDI/Trimethylol hexyllactone crosspolymer & Silica), 에이치디아이/트리메틸롤헥실락톤 & 실리카 & 디메티콘 (HDI/Trimethylol hexyllactone & silica & Dimethicone), 및 에이치디아이/피피지/폴리카프로락톤크로스폴리머 & 실리카 (HDI/PPG/Polycaprolactone crosspolymer & silica)로 이루어진 그룹에서 선택된 하나 이상을 포함할 수 있다.The polyurethane derivatives include, for example, HDI/Trimethylol hexyllactone crosspolymer & Silica, HDI/Trimethylol hexyllactone & silica & dimethicone (HDI/Trimethylol hexyllactone & silica & Dimethicone), and HDI/PPG/Polycaprolactone crosspolymer & silica (HDI/PPG/Polycaprolactone crosspolymer & silica).
일 구체예에서, 사이클로덱스트린은 6 내지 12개의 포도당이 각각 α-1,4 글리코시드 결합을 한 고리모양의 올리고당이며, 사이클로덱스트린 유도체로는 하이드록시프로필기로 치환된 덱스트린 7개 분자가 고리형태로 연결된 하이드록시프로필-β-사이클로덱스트린을 사용할 수 있다. In one embodiment, cyclodextrin is a ring-shaped oligosaccharide in which 6 to 12 glucose molecules each have α-1,4 glycosidic bonds, and the cyclodextrin derivative is a cyclic oligosaccharide composed of 7 dextrin molecules substituted with a hydroxypropyl group. Linked hydroxypropyl-β-cyclodextrin can be used.
본 발명의 실시예에서는 상기 파우더로 시판중인 플라스틱 파우더 D-400, D-800(Plastic Powder D-400, D-800, Nikko Chemicals Co. Ltd)을 사용한다. 상기 D-400 및 D-800은 에이치디아이/트리메틸롤헥실락톤크로스폴리머 & 실리카로, 상기 성분을 사용하여 난용성인 폴리페놀계 유효 성분의 조성물 내 안정성을 향상시킬 수 있다. In an embodiment of the present invention, commercially available plastic powders D-400 and D-800 (Plastic Powder D-400, D-800, Nikko Chemicals Co. Ltd) are used as the powder. The D-400 and D-800 are HDI/trimethylolhexylactone crosspolymer & silica, and the stability of poorly soluble polyphenol-based active ingredients in the composition can be improved by using the above ingredients.
본 발명에서 파우더의 함량은 특별히 제한되지 않으며, 폴리페놀계 유효 성분 안정화용 조성물 100 중량%에 대하여 0.1 내지 20 중량%, 0.3 내지 10 중량%, 0.5 내지 5 중량% 또는 1 내지 1.5 중량%로 포함될 수 있다. 상기 함량 범위에서 조성물 내에서 폴리페놀계 유효 성분의 안정성을 유지할 수 있다. 예를 들어, 파우더의 함량이 0.1 중량% 미만이면 상기 폴리페놀계 유효 성분의 안정성에 영향을 미치지 않으며, 20 중량%를 초과하면 뻑뻑함 또는 밀림 등의 사용감에 문제가 생길 우려가 있다. In the present invention, the content of the powder is not particularly limited and may be included at 0.1 to 20% by weight, 0.3 to 10% by weight, 0.5 to 5% by weight, or 1 to 1.5% by weight based on 100% by weight of the composition for stabilizing polyphenol-based active ingredients. You can. Within the above content range, the stability of the polyphenol-based active ingredient can be maintained in the composition. For example, if the powder content is less than 0.1% by weight, it does not affect the stability of the polyphenol-based active ingredient, and if it exceeds 20% by weight, there is a risk of problems with use such as stiffness or sticking.
본 발명에서 보습성분은 난용성 성분인 폴리페놀계 유효 성분의 용해를 위한 가용화제의 역할을 수행하며, 상기 보습성분을 통해 조성물의 안정성을 도모할 수 있다. In the present invention, the moisturizing ingredient serves as a solubilizer for dissolving the polyphenol-based active ingredient, which is a poorly soluble ingredient, and the stability of the composition can be promoted through the moisturizing ingredient.
이러한 보습성분의 종류는 특별히 제한되지 않으며, 베타인, 알라닐글루타민, 폴리쿼터늄-51, 니코틴아미드, 우레아 또는 그 유도체, 및 소듐피씨에이로 이루어진 그룹에서 선택된 하나 이상을 사용할 수 있다. The type of moisturizing ingredient is not particularly limited, and one or more selected from the group consisting of betaine, alanylglutamine, polyquaternium-51, nicotinamide, urea or its derivatives, and sodium PCA can be used.
특히, 니코틴아미드, 우레아 또는 그 유도체, 및 소듐피씨에이는 하이드로트로피(hydrotropy)한 성질을 지니는데, 하이드로트로피(hydrotropy)는 제 3 물질을 비교적 많이 첨가함으로써 물에 대하여 불용성 또는 난용성인 물질의 물에 대한 용해도를 증가시키는 현상을 의미한다. 즉, 본 발명에서는 상기 성분을 사용하여 폴리페놀계 유효 성분의 용해도를 증가시켜 조성물의 안정성을 향상시킬 수 있다.In particular, nicotinamide, urea or its derivatives, and sodium PCA have the property of hydrotropy, which is achieved by adding a relatively large amount of a third substance to water insoluble or poorly soluble substances. This refers to the phenomenon of increasing the solubility of . That is, in the present invention, the stability of the composition can be improved by using the above ingredients to increase the solubility of the polyphenol-based active ingredient.
상기 보습성분의 함량은 특별히 제한되지 않으며, 폴리페놀계 유효 성분 안정화용 조성물 100 중량%에 대하여 0.1 내지 20 중량%, 0.5 내지 15 중량% 또는 1.0 내지 10 중량%로 포함될 수 있다. 상기 함량 범위에서 조성물 내에서 폴리페놀계 유효 성분의 안정성을 유지할 수 있다. 예를 들어, 보습성분의 함량이 0.1 중량% 미만이면 상기 폴리페놀계 유효 성분의 안정성에 영향을 미치지 않으며, 20 중량%를 초과하면 사용감 및 제형의 안정성에 문제가 발생할 우려가 있다. The content of the moisturizing ingredient is not particularly limited, and may be included in an amount of 0.1 to 20% by weight, 0.5 to 15% by weight, or 1.0 to 10% by weight based on 100% by weight of the composition for stabilizing polyphenol-based active ingredients. Within the above content range, the stability of the polyphenol-based active ingredient can be maintained in the composition. For example, if the content of the moisturizing ingredient is less than 0.1% by weight, it does not affect the stability of the polyphenol-based active ingredient, and if it exceeds 20% by weight, there is a risk of problems with the feeling of use and stability of the formulation.
전술한 바와 같이, 본 발명에서는 파우더 및 보습성분을 포함하는 폴리페놀계 유효 성분 안정화용 조성물을 제공한다. 이러한 폴리페놀계 유효 성분 안정화용 조성물은 화장료 등의 용도로 사용될 수 있다.As described above, the present invention provides a composition for stabilizing polyphenol-based active ingredients containing powder and moisturizing ingredients. This composition for stabilizing polyphenol-based active ingredients can be used for purposes such as cosmetics.
하나의 양태로서, 본 발명은 본 발명에 따른 폴리페놀계 유효 성분 안정화용 조성물을 포함하는 화장료 조성물을 제공할 수 있다. In one aspect, the present invention can provide a cosmetic composition containing the composition for stabilizing polyphenol-based active ingredients according to the present invention.
본 발명에 있어서 상기 폴리페놀계 유효 성분 안정화용 조성물은 당업계에서 통상적으로 제조되는 어떠한 화장료 제형에도 첨가되어 사용될 수 있으며, 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제-함유 클렌징, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션, 또는 스프레이 등으로 제형화될 수 있으나, 이에 한정되는 것은 아니다. 보다 상세하게는, 화장수, 로션, 영양 크림, 마사지 크림, 에센스, 아이 크림, 클렌징 크림, 클렌징 폼, 클렌징 워터, 팩, 스프레이, 또는 파우더 등의 제형으로 제조될 수 있다.In the present invention, the composition for stabilizing polyphenol-based active ingredients can be added to and used in any cosmetic formulation commonly manufactured in the art, including solutions, suspensions, emulsions, pastes, gels, creams, lotions, powders, soaps, It may be formulated as a surfactant-containing cleansing, oil, powder foundation, emulsion foundation, wax foundation, or spray, but is not limited thereto. More specifically, it can be manufactured into formulations such as lotion, lotion, nutritional cream, massage cream, essence, eye cream, cleansing cream, cleansing foam, cleansing water, pack, spray, or powder.
본 발명에 있어서 상기 폴리페놀계 유효 성분 안정화용 조성물은 화장료에 통상적으로 사용되는 보습제, 오일, 자외선 차단제, 향료, 산화방지제, 또는 pH 조절제 등의 첨가제를 첨가하여 화장료 조성물로 제조될 수 있으나, 이에 한정되는 것은 아니다.In the present invention, the composition for stabilizing polyphenol-based active ingredients may be manufactured as a cosmetic composition by adding additives such as moisturizers, oils, sunscreens, fragrances, antioxidants, or pH regulators commonly used in cosmetics. It is not limited.
이하, 본 발명의 이해를 돕기 위하여 실시예 등을 들어 상세하게 설명하기로 한다. 그러나, 본 발명에 따른 실시예들은 여러 가지 다른 형태로 변형될 수 있으며, 본 발명의 범위가 하기 실시예들에 한정되는 것으로 해석돼서는 안 된다. 본 발명의 실시예들은 당 업계에서 평균적인 지식을 가진 자에게 본 발명을 보다 완전하게 설명하기 위해 제공되는 것이다.Hereinafter, to aid understanding of the present invention, it will be described in detail through examples. However, the embodiments according to the present invention may be modified into various other forms, and the scope of the present invention should not be construed as limited to the following embodiments. Embodiments of the present invention are provided to more completely explain the present invention to those skilled in the art.
실시예 Example
실시예 1 내지 3 및 비교예 1 내지 5Examples 1 to 3 and Comparative Examples 1 to 5
하기 표 1의 함량(중량%, wt%) 구성을 가지는 화장료 조성물을 제조하였다.A cosmetic composition having the content (weight%, wt%) shown in Table 1 below was prepared.
먼저, 유상 원료 1 내지 7, 수상 원료 8 내지 15, 및 폴리올상 원료 16 내지 18을 각각 75℃로 가열 용해하였다. 그 후, 폴리올상을 수상에 첨가하여 균일하게 섞어준 후, 유상을 수상에 첨가하고 호모믹서를 사용하여 6000 rpm 조건에서 5 분간 유화시킨 후 냉각하였다. 그 후, 50 내지 55℃에서 향을 투입한 후 호모믹서를 사용하여 6000 rpm 조건에서 다시 5 분간 유화시킨 후, 30℃까지 냉각하여 화장료 조성물을 최종 제조하였다.First, oil phase raw materials 1 to 7, water phase raw materials 8 to 15, and polyol phase raw materials 16 to 18 were each heated and dissolved at 75°C. After that, the polyol phase was added to the water phase and mixed uniformly, and then the oil phase was added to the water phase, emulsified for 5 minutes at 6000 rpm using a homomixer, and then cooled. After that, the fragrance was added at 50 to 55°C, emulsified again at 6000 rpm for 5 minutes using a homomixer, and then cooled to 30°C to prepare the final cosmetic composition.
실험예 1: 제형 안정성 평가Experimental Example 1: Formulation stability evaluation
실시예 및 비교예에서 제조된 화장료 조성물에 대하여 제형 안정성 평가를 수행하였다. Formulation stability evaluation was performed on the cosmetic compositions prepared in Examples and Comparative Examples.
제형 안정성 평가는 0℃, 40℃, 45℃, 50℃ 및 cycle chamber(-10℃ → 45℃ → -10℃)에서 2개월간 보관한 후, 안정성을 관찰하여 평가하였다. Formulation stability was evaluated by observing stability after storage for 2 months at 0℃, 40℃, 45℃, 50℃ and cycle chamber (-10℃ → 45℃ → -10℃).
평가는 제니스테인의 석출 여부에 따라 매우양호: O, 미량석출: △, 석출: X 로 하여 표시하였다.The evaluation was indicated as very good: O, trace amount of precipitation: △, and precipitation:
표 2에서 보는 바와 같이, 실시예 1 내지 3에서 제조된 화장료 조성물은 비교예 1 내지 5에서 제조된 화장료 조성물과 비교하여 제니스테인의 석출 없이 안정함을 확인하였다.As shown in Table 2, the cosmetic compositions prepared in Examples 1 to 3 were confirmed to be stable without precipitation of genistein compared to the cosmetic compositions prepared in Comparative Examples 1 to 5.
실험예 2: 피부 1차 자극성 시험(폐쇄 첩포 실험)Experimental Example 2: Primary skin irritation test (closed patch experiment)
실시예 및 비교예에서 제조된 화장료 조성물에 대하여 피부 자극성 평가를 수행하였다. Skin irritation evaluation was performed on the cosmetic compositions prepared in Examples and Comparative Examples.
건강한 성인 남녀 50명을 대상으로 등 부위에 각 시료의 일정량(0.2g)을 24시간 첩포한 후, 핀챔버를 제거하고 4시간 경과한 다음 육안으로 피부상태 변화를 판독하여 그 결과를 하기 표 5에 나타내었다. After applying a certain amount (0.2g) of each sample to the back area of 50 healthy adult men and women for 24 hours, the pin chamber was removed, and after 4 hours, the change in skin condition was read with the naked eye, and the results are shown in Table 5 below. shown in
판정 기준 및 자극도는 하기와 같이 평가하였다.The judgment criteria and irritation level were evaluated as follows.
<판정 기준> <Judgment criteria>
*- : 홍반이나 특이한 현상 없음.*-: No erythema or unusual symptoms.
+-: 주위보다 약간 붉어짐+-: Slightly redder than surrounding area
+: 주위보다 현저히 붉어짐+: Significantly redder than the surroundings
++: 주위보다 심하게 붉어지고 부풀어 오름.++: Severe redness and swelling compared to the surrounding area.
자극도 = [{(+-)수×1} + {(+)수×2} + {(++)수×3}] / 피시험자수Stimulus level = [{(+-) number × 1} + {(+) number × 2} + {(++) number × 3}] / Number of test subjects
실시예2
실시예3
비교예1
비교예2
비교예3
비교예4
비교예5Example 1
Example 2
Example 3
Comparative Example 1
Comparative example 2
Comparative example 3
Comparative example 4
Comparative Example 5
50
50
50
50
50
50
5050
50
50
50
50
50
50
50
-
-
-
-
-
-
--
-
-
-
-
-
-
-
-
-
-
1
-
-
--
-
-
-
One
-
-
-
1
1
2
4
2
3
1-
One
One
2
4
2
3
One
49
49
48
45
48
47
4950
49
49
48
45
48
47
49
0.02
0.02
0.04
0.12
0.04
0.06
0.020.00
0.02
0.02
0.04
0.12
0.04
0.06
0.02
상기 표 3에서 보는 바와 같이, 전체적으로 허용수준이나, 비교예에서 제조된 화장료 조성물이 실시예에서 제조된 화장료 조성물보다 상대적으로 높은 자극도를 가지는 경향을 보인다. As shown in Table 3, although the overall level is acceptable, the cosmetic composition prepared in Comparative Examples tends to have a relatively higher level of irritation than the cosmetic composition prepared in Examples.
따라서, 본 발명에 따른 화장료 조성물(실시예 1 내지 3)이 피부에 안전하다는 것을 확인할 수 있다.Therefore, it can be confirmed that the cosmetic composition according to the present invention (Examples 1 to 3) is safe for the skin.
Claims (7)
유상을 첨가하는 단계를 포함하며,
상기 파우더는 다공성 고분자 입자, 및 사이클로덱스트린 또는 그 유도체로 이루어진 그룹에서 선택된 하나 이상을 포함하고,
상기 보습성분은 베타인, 알라닐글루타민, 폴리쿼터늄-51, 니코틴아미드, 우레아 또는 그 유도체, 및 소듐피씨에이로 이루어진 그룹에서 선택된 하나 이상을 포함하는 것인,
2개월 동안 보관하더라도 폴리페놀계 유효 성분이 석출되지 않는 조성물의 제조 방법.
Adding a polyol phase containing a polyphenol-based active ingredient and powder to an aqueous phase containing a moisturizing ingredient; and
It includes adding an oil phase,
The powder contains at least one selected from the group consisting of porous polymer particles and cyclodextrin or a derivative thereof,
The moisturizing ingredient includes one or more selected from the group consisting of betaine, alanylglutamine, polyquaternium-51, nicotinamide, urea or its derivatives, and sodium PCA,
A method for producing a composition in which the polyphenol-based active ingredient does not precipitate even when stored for 2 months.
폴리페놀계 유효 성분은 제니스테인, 다이드제인, 프란게니딘, 폴리다틴, 디오스메틴, 메이스리그난, 아시아티코사이드, 진세노사이드알이, 속수자 종자추출물, 글리시테인, 퀘르세틴, 카테킨, 페오놀, 레스베라트롤, 헤스페레틴, 및 레스페리딘으로 이루어진 그룹에서 선택된 하나 이상을 포함하는 조성물의 제조 방법.
According to claim 1,
The polyphenol-based active ingredients are genistein, daidzein, frangenidin, polydatin, diosmetin, macelignan, asiaticoside, ginsenoside egg, prickly pear seed extract, glycitein, quercetin, catechin, phenol, A method for producing a composition comprising at least one selected from the group consisting of resveratrol, hesperetin, and resperidin.
다공성 고분자 입자는 폴리우레탄 유도체, 실리카(Silica), 다공성 셀룰로오스(Porous Cellulose), 폴리메틸메타아크릴레이트 (Polymethylmethacrylate), 알릴메타아크릴레이트 크로스폴리머(Allyl methacrylates crosspolymer) 및 폴리아미드(Polyamide)로 이루어진 그룹에서 선택된 하나 이상을 포함하는 조성물의 제조 방법.
According to claim 1,
Porous polymer particles are from the group consisting of polyurethane derivatives, silica, porous cellulose, polymethylmethacrylate, allyl methacrylates crosspolymer, and polyamide. A method of preparing a composition comprising one or more selected substances.
폴리우레탄 유도체는 에이치디아이/트리메틸롤헥실락톤 크로스폴리머 & 실리카(HDI/Trimethylol hexyllactone crosspolymer & Silica), 에이치디아이/트리메틸롤헥실락톤 & 실리카 & 디메티콘 (HDI/Trimethylol hexyllactone & silica & Dimethicone), 및 에이치디아이/피피지/폴리카프로락톤크로스폴리머 & 실리카 (HDI/PPG/Polycaprolactone crosspolymer & silica) 로 이루어진 그룹에서 선택된 하나 이상을 포함하는 조성물의 제조 방법.
According to claim 3,
Polyurethane derivatives include HDI/Trimethylol hexyllactone crosspolymer & Silica, HDI/Trimethylol hexyllactone & silica & Dimethicone, and HDI/Trimethylol hexyllactone & silica & Dimethicone. A method for producing a composition comprising at least one selected from the group consisting of HDI/PPG/Polycaprolactone crosspolymer & silica.
파우더는 조성물 100 중량%에 대하여 0.1 내지 20 중량% 포함하는 조성물의 제조 방법.
According to claim 1,
A method of producing a composition comprising 0.1 to 20% by weight of powder based on 100% by weight of the composition.
보습성분은 조성물 100 중량%에 대하여 0.1 내지 20 중량% 포함하는 조성물의 제조 방법.
According to claim 1,
A method for producing a composition comprising 0.1 to 20% by weight of the moisturizing ingredient based on 100% by weight of the composition.
A cosmetic composition comprising a composition prepared by the method for producing the composition according to claim 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020230026734A KR102585227B1 (en) | 2015-11-30 | 2023-02-28 | Composition for stabilizing polyphenolic effective ingredient |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150168799A KR102506399B1 (en) | 2015-11-30 | 2015-11-30 | Composition for stabilizing polyphenolic effective ingredient |
KR1020230026734A KR102585227B1 (en) | 2015-11-30 | 2023-02-28 | Composition for stabilizing polyphenolic effective ingredient |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020150168799A Division KR102506399B1 (en) | 2015-11-30 | 2015-11-30 | Composition for stabilizing polyphenolic effective ingredient |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20230038154A KR20230038154A (en) | 2023-03-17 |
KR102585227B1 true KR102585227B1 (en) | 2023-10-06 |
Family
ID=59221392
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020150168799A Active KR102506399B1 (en) | 2015-11-30 | 2015-11-30 | Composition for stabilizing polyphenolic effective ingredient |
KR1020230026734A Active KR102585227B1 (en) | 2015-11-30 | 2023-02-28 | Composition for stabilizing polyphenolic effective ingredient |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020150168799A Active KR102506399B1 (en) | 2015-11-30 | 2015-11-30 | Composition for stabilizing polyphenolic effective ingredient |
Country Status (1)
Country | Link |
---|---|
KR (2) | KR102506399B1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115969716B (en) * | 2022-11-21 | 2025-02-07 | 上海其然生物科技有限公司 | Resveratrol inclusions and preparation method and application thereof |
KR102743733B1 (en) | 2022-12-20 | 2024-12-18 | 한국콜마주식회사 | Complex for stabilizing poorly soluble ingredients and composition containing the same |
CN118415904A (en) * | 2024-05-06 | 2024-08-02 | 赣州华汉生物科技有限公司 | Stable composition containing polydatin and preparation method thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011021001A (en) * | 2009-06-01 | 2011-02-03 | Lvmh Recherche | Use of high polyphenol plant extract as antioxidant combined with moisturizer or humectant |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100531269B1 (en) | 2001-12-04 | 2005-11-28 | 주식회사 삼양사 | Polymeric compositions for forming micelles or nanoparticles which are stable in aqueous solution |
JP2004131500A (en) * | 2002-09-19 | 2004-04-30 | Fancl Corp | Anti-aging or improving agent for skin |
KR101129410B1 (en) * | 2005-06-14 | 2012-03-26 | 주식회사 엘지생활건강 | Hair-styling cosmetic composition in the form of water-in-silicone emulsion |
KR101114659B1 (en) | 2005-10-14 | 2012-03-05 | (주)아모레퍼시픽 | Nanoparticle stabilizing the oil soluble active ingredients by using biodegradable polymers and the process for preparing the same |
KR100811465B1 (en) | 2006-10-13 | 2008-03-07 | (주)아모레퍼시픽 | Cosmetic composition that simultaneously enlarges pores and removes sebum |
KR20110062708A (en) * | 2009-12-04 | 2011-06-10 | 주식회사 선진화학 | Porous polymethyl methacrylate powder containing functional material for cosmetics, preparation method thereof and cosmetic composition containing same |
KR101914157B1 (en) * | 2011-08-24 | 2018-12-31 | (주)아모레퍼시픽 | Cosmetic composition comprising camellia sinensis constituents |
-
2015
- 2015-11-30 KR KR1020150168799A patent/KR102506399B1/en active Active
-
2023
- 2023-02-28 KR KR1020230026734A patent/KR102585227B1/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011021001A (en) * | 2009-06-01 | 2011-02-03 | Lvmh Recherche | Use of high polyphenol plant extract as antioxidant combined with moisturizer or humectant |
Also Published As
Publication number | Publication date |
---|---|
KR20170062961A (en) | 2017-06-08 |
KR102506399B1 (en) | 2023-03-06 |
KR20230038154A (en) | 2023-03-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102585227B1 (en) | Composition for stabilizing polyphenolic effective ingredient | |
AU2011318580B2 (en) | Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds | |
EP2110121B1 (en) | Cosmetic and dermatological compositions in particular for the treatment of keratin containing substrates | |
EP1492488A2 (en) | Cross-linked cosmetic or pharmaceutical phospholipid-containing gels and emulsions based on ethylene oxide-containing or propylene oxide-containing emulsifiers | |
EP2731582B1 (en) | Charge providers for a vesicular carrier system of a uv protection composition for the skin or hair | |
KR101821207B1 (en) | Solubilization cosmetic composition containing oleanolic acid | |
KR102439781B1 (en) | Oil-in-water, low-viscosity cosmetic composition with stabilized high-content oil | |
KR20130092172A (en) | Oil-in-water solid type low irritation and high moisturizing cosmetic composition comprising polyol and emulsifier and manufacturing method thereof | |
KR102142311B1 (en) | Skin external composition comprising tangeretin | |
KR20130086611A (en) | Cosmetic composition | |
EP1541126A1 (en) | Cosmetic and dermatological composition comprising a combination of a green colouring agent and an antiinflammatory agent | |
KR102692754B1 (en) | Cosmetic composition comprising Centella asiatica extract or Triterpene isolated therefrom with high content, and the method for preparing the same | |
KR101663775B1 (en) | Composition for stabilizing polyphenolic effective ingredient | |
CN109562136A (en) | It treats skin disorder or mitigates the method for skin disorder seriousness | |
KR20220095126A (en) | Gel composition and kit comprising physically crosslinked polymer hyaluronic acid or salt thereof | |
KR102381622B1 (en) | Stabilizing method of rice bran wax and cosmetic composition containing the stabilized rice bran wax | |
KR20200048476A (en) | Crosslinked hyaluronic acid compositions and method of producing the same | |
KR102324870B1 (en) | Cosmetic composition stabilizing insoluble ingredient | |
KR20190025307A (en) | Oil in water type cosmetic composition containing stabilized high-content oil inner phase | |
KR20210017476A (en) | A freeze-dried formulation composition and a skin external application cosmetic kit comprising the same | |
KR102080034B1 (en) | Nanoemulsion composition and manufacturing method thereof | |
KR102502255B1 (en) | Azulene emulsion composition for wound healing, skin regeneration or irritation alleviation effect, and preparing method of the same | |
KR102829586B1 (en) | Hyaluronic acid hydrogel with ceramide bonded thereto | |
KR102802924B1 (en) | Nanoparticle composition for cosmetics based on plant-derived protein | |
KR102609651B1 (en) | Method for stabilizing poorly soluble materials through the clathrate effect of cross-linked hyaluronic acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A107 | Divisional application of patent | ||
PA0107 | Divisional application |
St.27 status event code: A-0-1-A10-A16-div-PA0107 St.27 status event code: A-0-1-A10-A18-div-PA0107 |
|
PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
St.27 status event code: A-1-2-D10-D22-exm-PE0701 |
|
PR0701 | Registration of establishment |
St.27 status event code: A-2-4-F10-F11-exm-PR0701 |
|
PR1002 | Payment of registration fee |
Fee payment year number: 1 St.27 status event code: A-2-2-U10-U11-oth-PR1002 |
|
PG1601 | Publication of registration |
St.27 status event code: A-4-4-Q10-Q13-nap-PG1601 |